Tag: Industry Reports
The global handheld ultrasound imaging devices market is projected
The increasing medical diagnostic imaging burden has compelled industry players to develop advanced handheld ultrasound scanners that will enable physicians to accurately visualize all major organ systems for diagnostic purposes
The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030, predicts Roots Analysis
Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world
The Companion Diagnostics Development Services Market
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise
The nuclear medicine and radiopharmaceutical manufacturing
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharm...
The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis
Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillar...
The “Encapsulated Cell Therapies and Encapsulation Technologies Market”
? A detailed assessment of the current market landscape of encapsulated cell therapies and affiliated technologies, highlighting various target disease indications, phase of development, encapsulation method, type of cells / API, and route of administrati...
The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis
Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages
Patient Recruitment and Retention Services, 2019-2030 - RootsAnalysis
A detailed assessmentof the current market landscape, including information on drug developer(s
Patient Recruitment and Retention Services Marker
A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies
The patient recruitment and retention services market - RootsAnalysis
Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Marker, 2019-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
The patient recruitment and retention services market- Rootsanalysis
A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers
More than 100 industry players and over 60 non-industry players currently
Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years.
Growing at an annualized rate of over 16.5%
Theapproval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased theinterest of pharma stakeholders in cell therapies; further, owing to thetechnical challenges in this field, outsourcing manufacturing operations hasbecome a necessity
The cell therapy manufacturing market is projected to grow
Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity.
The cell therapy manufacturing market is estimated - RootsAnalysis
Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers.
